Findings

What do systematic reviews say?

2,661 questions · 2,751 findings · 453 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 593 · 21.6%GRADE not reported 277 · 10.1%Very low 538 · 19.6%Low 712 · 25.9%Moderate 516 · 18.8%High 115 · 4.2%

SHORT vs long duration of antimicrobials

Stool volume · Adults and children with cholera diarrhoea

1 finding from 1 review

Antimicrobial drugs for treating cholera 2014 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 496 participants
Low

SHORT vs long duration of antimicrobials

Bacteriological failure · Adults and children with cholera diarrhoea

Short may leads to higher bacteriological failure compared with long duration of antimicrobials (low certainty).

1 finding from 1 review

Antimicrobial drugs for treating cholera 2014 · Cochrane Headline outcomes only
RR 1.53 [1.01, 2.32]
9 studies · 672 participants
Low

Antibiotics (short duration) vs antibiotics (long duration) postpartum

Maternal and neonatal mortality · women with management of intra‐amniotic infection

1 finding from 1 review

Antibiotic regimens for management of intra‐amniotic infection 2014 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Antibiotics (short duration) vs antibiotics (long duration) postpartum

Wound infection · women with management of intra‐amniotic infection

Antibiotics (short duration) showed no clear difference in wound infection compared with antibiotics (long duration) postpartum (low certainty).

1 finding from 1 review

Antibiotic regimens for management of intra‐amniotic infection 2014 · Cochrane Headline outcomes only
RR 1.87 [0.17, 20.37]
1 study · 292 participants
Low

Antibiotics (short duration) vs antibiotics (long duration) postpartum

Length of hospital stay · women with management of intra‐amniotic infection

1 finding from 1 review

Antibiotic regimens for management of intra‐amniotic infection 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 292 participants
Moderate

Antibiotics (short duration) vs antibiotics (long duration) postpartum

Need for additional antibiotic therapy · women with management of intra‐amniotic infection

1 finding from 1 review

Antibiotic regimens for management of intra‐amniotic infection 2014 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Antibiotics (short duration) vs antibiotics (long duration) postpartum

Endometritis · women with management of intra‐amniotic infection

1 finding from 1 review

Antibiotic regimens for management of intra‐amniotic infection 2014 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Antibiotics (short duration) vs antibiotics (long duration) postpartum

Postpartum readmission for endometritis · women with management of intra‐amniotic infection

1 finding from 1 review

Antibiotic regimens for management of intra‐amniotic infection 2014 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Antibiotics (short duration) vs antibiotics (long duration) postpartum

Treatment failure (vaginal and cesarean delivery) · women with management of intra‐amniotic infection

Antibiotics (short duration) showed no clear difference in treatment failure (vaginal and cesarean delivery) compared with antibiotics (long duration) postpartum (low certainty).

1 finding from 1 review

Antibiotic regimens for management of intra‐amniotic infection 2014 · Cochrane Headline outcomes only
RR 1.31 [0.42, 4.02]
1 study · 292 participants
Low

One-stage crestal-approach sinus lift with autogenous bone and 8 mm implants vs Lateral-window sinus lift with 50% autogenous bone/50% Bio-Oss and implants at least 10 mm long

Augmentation (graft) procedure failure · Patients with 3 to 6 mm of residual bone height at the sinus floor

One-stage crestal-approach sinus lift with autogenous bone and 8 mm… showed no clear difference in augmentation (graft) procedure failure compared with lateral-window sinus lift with 50% autogenous bone/50% Bio-Oss and…; GRADE not reported.

1 finding from 1 review

Interventions for replacing missing teeth: augmentation procedures of the maxillary sinus 2014 · Cochrane All outcomes
5 years after loading
OR 0.18 [0.01, 4.01]
1 study · 40 participants
GRADE not reported

Internal jugular vs subclavian insertion: long‐term catheterization

Exit‐site infection · cancer patients

Internal jugular showed no clear difference in catheter‐related infectious complications ‐ Exit site infection compared with subclavian insertion: long‐term catheterization (low certainty).

1 finding from 1 review

Central venous access sites for the prevention of venous thrombosis, stenosis and infection 2012 · Cochrane Headline outcomes only
RR 7 [0.88, 55.86]
1 study · 200 participants
Low

Internal jugular vs subclavian insertion: long‐term catheterization

Catheter‐related infectious complications ‐ Port‐related bacteraemia and/or pocket infections · cancer patients

Internal jugular showed no clear difference in catheter‐related infectious complications ‐ Port‐related bacteraemia… compared with subclavian insertion: long‐term catheterization (moderate certainty).

1 finding from 1 review

Central venous access sites for the prevention of venous thrombosis, stenosis and infection 2012 · Cochrane Headline outcomes only
RR 0.35 [0.04, 3.32]
1 study · 240 participants
Moderate

Internal jugular vs subclavian insertion: long‐term catheterization

Catheter‐related thrombotic complications · cancer patients

Internal jugular showed no clear difference in catheter‐related thrombotic complications compared with subclavian insertion: long‐term catheterization (moderate certainty).

1 finding from 1 review

Central venous access sites for the prevention of venous thrombosis, stenosis and infection 2012 · Cochrane Headline outcomes only
RR 1.97 [0.87, 4.48]
1 study · 240 participants
Moderate

Internal jugular vs subclavian insertion: long‐term catheterization

Immediate mechanical complications ‐ Total mechanical complications · cancer patients

Internal jugular showed no clear difference in immediate mechanical complications ‐ Total mechanical complications compared with subclavian insertion: long‐term catheterization (low certainty).

1 finding from 1 review

Central venous access sites for the prevention of venous thrombosis, stenosis and infection 2012 · Cochrane Headline outcomes only
RR 1 [0.21, 4.84]
2 studies · 468 participants
Low

Internal jugular vs subclavian insertion: long‐term catheterization

Immediate mechanical complications ‐ Major mechanical complications · cancer patients

Internal jugular showed no clear difference in immediate mechanical complications ‐ Major mechanical complications compared with subclavian insertion: long‐term catheterization (low certainty).

1 finding from 1 review

Central venous access sites for the prevention of venous thrombosis, stenosis and infection 2012 · Cochrane Headline outcomes only
RR 0.33 [0.01, 8.09]
2 studies · 468 participants
Low

Internal jugular vs subclavian insertion: long‐term catheterization

Late mechanical complications · cancer patients

Internal jugular showed no clear difference in late mechanical complications compared with subclavian insertion: long‐term catheterization (low certainty).

1 finding from 1 review

Central venous access sites for the prevention of venous thrombosis, stenosis and infection 2012 · Cochrane Headline outcomes only
RR 1.67 [0.41, 6.79]
2 studies · 468 participants
Low

Paliperidone palmitate vs risperidone long‐acting injection

Death by end of trial · patients with schizophrenia

Paliperidone palmitate showed no clear difference in death Reported by trial author compared with risperidone long‐acting injection (low certainty).

1 finding from 1 review

Paliperidone palmitate for schizophrenia 2012 · Cochrane Headline outcomes only
RR 3.62 [0.6, 21.89]
2 studies · 1967 participants
Low

Paliperidone palmitate vs risperidone long‐acting injection

No clinically important change Number of people whose PANSS score either increased or did not decrease by at least 30% from the beginning to the end of the trial · patients with schizophrenia

Paliperidone palmitate showed no clear difference in no clinically important change Number of people whose PANSS score… compared with risperidone long‐acting injection (low certainty).

1 finding from 1 review

Paliperidone palmitate for schizophrenia 2012 · Cochrane Headline outcomes only
RR 1.03 [0.93, 1.14]
2 studies · 1587 participants
Low

Paliperidone palmitate vs risperidone long‐acting injection

Relapse: recurrence of psychotic symptoms Reported by trial author as adverse event · patients with schizophrenia

Paliperidone palmitate showed no clear difference in relapse: recurrence of psychotic symptoms Reported by trial authors… compared with risperidone long‐acting injection (moderate certainty).

1 finding from 1 review

Paliperidone palmitate for schizophrenia 2012 · Cochrane Headline outcomes only
RR 1.23 [0.98, 1.53]
2 studies · 1961 participants
Moderate

Paliperidone palmitate vs risperidone long‐acting injection

Cost ‐ not measured · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Paliperidone palmitate for schizophrenia 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found